Want to see HK:8217 full AI Analyst Report?
8217 Stock Chart & Stats
HK$0.38
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.38
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.10 - HK$0.41
Previous CloseN/A
Volume100.00K
Average Volume (3M)973.87K
Market Cap
HK$32.00M
Enterprise ValueHK$60.90M
Total Cash (Recent Filing)HK$54.16M
Total Debt (Recent Filing)HK$12.00M
Price to Earnings (P/E)1.4
Beta0.15
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding301,860,000
10 Day Avg. Volume383,125
30 Day Avg. Volume973,865
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.32
Price to Sales (P/S)1.74
P/FCF Ratio-8.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable LeverageStable, moderate debt levels (c. HKD12m and D/E ~0.44) reduce near-term refinancing and interest burden risks. This financial headroom supports bidding for government contracts and absorbing project timing swings, providing durable balance-sheet flexibility while profits recover.
Contracted Public-sector DemandThe business model is centered on tendered civil-engineering contracts for government/public bodies. Ongoing public infrastructure and urban development create a structural pipeline of projects and recurring tender opportunities, supporting revenue visibility and utilization over multiple months to years.
Operational Improvement In 2025A material narrowing of losses and margin improvement in 2025 suggests better project execution, pricing discipline or cost control that could stick. If sustained, these operational gains can translate into progressively smaller losses and eventual return to profitability over the medium term.
Bears Say
Multi-year Net LossesPersistent multi-year net losses indicate the core project economics have been insufficient to generate returns. Long-term unprofitability erodes equity, constrains reinvestment, and undermines the ability to compete on contracts that require working-capital or performance guarantees.
Volatile Cash GenerationIntermittent negative operating and free cash flow raises execution and working-capital risks for a contract-driven business. Volatile cash reduces the company's ability to fund bid bonds, mobilization costs and unforeseen overruns, increasing reliance on external financing or owner injections over time.
Shrinking Revenue BaseA materially smaller revenue base reduces scale benefits and bargaining power with suppliers, making margins more sensitive to fixed costs. Continued top-line contraction can make recovery harder, limiting ability to smooth overheads and increasing vulnerability to competitive pressure in tenders.
8217 FAQ
What was Luen Wong Group Holdings Ltd.’s price range in the past 12 months?
Luen Wong Group Holdings Ltd. lowest stock price was HK$0.10 and its highest was HK$0.41 in the past 12 months.
What is Luen Wong Group Holdings Ltd.’s market cap?
Luen Wong Group Holdings Ltd.’s market cap is HK$32.00M.
When is Luen Wong Group Holdings Ltd.’s upcoming earnings report date?
Luen Wong Group Holdings Ltd.’s upcoming earnings report date is Nov 17, 2026 which is in 126 days.
How were Luen Wong Group Holdings Ltd.’s earnings last quarter?
Luen Wong Group Holdings Ltd. released its earnings results on Jun 30, 2026. The company reported HK$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.006.
Is Luen Wong Group Holdings Ltd. overvalued?
According to Wall Street analysts Luen Wong Group Holdings Ltd.’s price is currently Overvalued.
Does Luen Wong Group Holdings Ltd. pay dividends?
Luen Wong Group Holdings Ltd. does not currently pay dividends.
What is Luen Wong Group Holdings Ltd.’s EPS estimate?
Luen Wong Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Luen Wong Group Holdings Ltd. have?
Luen Wong Group Holdings Ltd. has 301,860,000 shares outstanding.
What happened to Luen Wong Group Holdings Ltd.’s price movement after its last earnings report?
Luen Wong Group Holdings Ltd. reported an EPS of HK$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.077%.
Which hedge fund is a major shareholder of Luen Wong Group Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8217
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Luen Wong Group Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.93%
12-Months-Change
Fundamentals
Return on Equity
57.15%
Trailing 12-Months
Asset Growth
15.24%
Trailing 12-Months
Company Description
Luen Wong Group Holdings Ltd.
"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure development, specifically road and drainage systems. This encompasses the building and enhancement of local roads and carriageway junctions, along with related facilities such as footpaths, planting zones, drainage networks, sewer lines, water mains, and utility relocation solutions. Additionally, the company undertakes foundational structural projects, including the erection of reinforced concrete structures for bridges and retaining walls. Furthermore, their expertise extends to site preparation, involving excavation and filling operations essential for new site development or future construction. The entity previously operated under the name WMHW Holdings Limited before rebranding as Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Established in 2015, the firm maintains its headquarters in Causeway Bay, Hong Kong."
Technical Analysis
Kwong Luen Engineering Holdings Limited
―
New Concepts Holdings Ltd
―
Steve Leung Design Group Limited
―
Sam Woo Construction Group Ltd.
―
K W Nelson Interior Design and Contracting Group Limited
―